Persistent Impairment of T-Cell Regeneration in a Patient with Activated PI3K δ Syndrome

被引：0

作者：

Fumihiro Goto

Toru Uchiyama

Yumiko Nakazawa

Kohsuke Imai

Toshinao Kawai

Masafumi Onodera

机构：

[1] National Center for Child Health and Development,Department of Human Genetics

[2] Tokyo Medical and Dental University,Department of Community Pediatrics, Perinatal and Maternal Medicine, Graduate School of Medical and Dental Sciences

来源：

Journal of Clinical Immunology | 2017年 / 37卷

关键词：

Rapamycin; Hematopoietic Stem Cell Transplantation; Rapamycin Treatment; Quantitative Polymerase Chain Reaction Analysis; mTOR Inhibitor Rapamycin;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：347 / 350

页数：3

共 50 条

[31] Dissecting the cellular defects that lead to activated PI3K δ Syndrome (APDS)
Lau, Anthony
Bier, Julia
Brink, Robert
Tangye, Stuart
Deenick, Elissa
EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 110 - 110
[32] Disseminated Ureaplasma urealyticum Infection and Hyperammonemic Encephalopathy in a Patient With Activated PI3K Delta Syndrome 2
Lai, Yi Wye
Lin, Ray Junhao
Maiwald, Matthias
Lim, Gareth Zigui
Rao, Pooja
Koh, Tse Hsien
Puah, Ser Hon
Tan, Teck Choon
Howe, Hwee Siew
Lim, Xin Rong
OPEN FORUM INFECTIOUS DISEASES, 2025, 12 (02):
[33] Roles of PLC-β2, -β3, and PI3K in T-cell migration to SDF 1-α.
Bach, TL
Chen, QM
Jordan, MS
Wu, DQ
Zigmond, SH
Abrams, CS
BLOOD, 2003, 102 (11) : 768A - 768A
[34] Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia
Monique Dail
Jason Wong
Jessica Lawrence
Daniel O’Connor
Joy Nakitandwe
Shann-Ching Chen
Jin Xu
Leslie B. Lee
Keiko Akagi
Qing Li
Jon C. Aster
Warren S. Pear
James R. Downing
Deepak Sampath
Kevin Shannon
Nature, 2014, 513 : 512 - 516
[35] High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia
Gutierrez, Alejandro
Sanda, Takaomi
Grebliunaite, Ruta
Carracedo, Arkaitz
Salmena, Leonardo
Ahn, Yebin
Dahlberg, Suzanne
Neuberg, Donna
Moreau, Lisa A.
Winter, Stuart S.
Larson, Richard
Zhang, Jianhua
Protopopov, Alexei
Chin, Lynda
Pandolfi, Pier Paolo
Silverman, Lewis B.
Hunger, Stephen P.
Sallan, Stephen E.
Look, A. Thomas
BLOOD, 2009, 114 (03) : 647 - 650
[36] PI3K regulates pleckstrin-2 in T-cell cytoskeletal re-organization
Bach, TL
Kerr, WT
Abrams, CS
BLOOD, 2005, 106 (11) : 924A - 924A
[37] Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia
Dail, Monique
Wong, Jason
Lawrence, Jessica
O'Connor, Daniel
Nakitandwe, Joy
Chen, Shann-Ching
Xu, Jin
Lee, Leslie B.
Akagi, Keiko
Li, Qing
Aster, Jon C.
Pear, Warren S.
Downing, James R.
Sampath, Deepak
Shannon, Kevin
NATURE, 2014, 513 (7519) : 512 - +
[38] PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia
Silveira, Andre Bortolini
Albertoni Laranjeira, Angelo Brunelli
Libanio Rodrigues, Gisele Olinto
Leal, Paulo Cesar
Cardoso, Bruno Antonio
Barata, Joao Taborda
Yunes, Rosendo Augusto
Tonin Zanchin, Nilson Ivo
Brandalise, Silvia Regina
Yunes, Jose Andres
ONCOTARGET, 2015, 6 (15) : 13105 - 13118
[39] Inhibiting glioblastoma multiforme PI3K/mTOR signaling without impacting T-cell function
不详
IMMUNOTHERAPY, 2010, 2 (01) : 10 - 11
[40] Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kd inhibitor leniolisib
Rao, V. Koneti
Webster, Sharon
Dalm, Virgil A. S. H.
Sediva, Anna
van Hagen, P. Martin
Holland, Steven
Rosenzweig, Sergio D.
Christ, Andreas D.
Sloth, Birgitte
Cabanski, Maciej
Joshi, Aniket D.
de Buck, Stefan
Doucet, Julie
Guerini, Danilo
Kalis, Christoph
Pylvaenaeinen, Ilona
Soldermann, Nicolas
Kashyap, Anuj
Uzel, Gulbu
Lenardo, Michael J.
Patel, Dhavalkumar D.
Lucas, Carrie L.
Burkhart, Christoph
BLOOD, 2017, 130 (21) : 2307 - 2316

← 1 2 3 4 5 →